Trudy H. Grossman will serve as vice president of research and and Roger Léger will become vice president of chemistry, formulation and development at Farmington biotech firm Azitra Inc.
Grossman has extensive research experience in bacterial genetics, microbiology and molecular biology, and has led several drug discovery and preclinical programs, supporting the clinical development of novel drug candidates. Léger is a medicinal chemist with 25 years of biopharmaceutical experience in companies at a variety of stages of growth.
